Aortic valve insufficiency treatment cost in Republic of Korea typically runs from $28,500 to $44,500 for surgical replacement, while minimally invasive transcatheter aortic valve implantation (TAVI) ranges from $28,500 to $44,000. Total expenses depend on the valve type, surgical technique, and hospital tier. Patients often save 30–50% compared to US medical costs. Seoul and Incheon are the primary destinations for these advanced cardiac procedures.
Typical Aortic Valve Insufficiency Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex cases, choosing a high-volume center is critical for safety. Asan Medical Center is a top-tier choice. It performs 45% of all heart transplants in South Korea. Their 90% organ transplant success rate demonstrates exceptional surgical precision. Patients seeking innovation should consider Seoul National University Bundang Hospital. It is Korea's first digital hospital and utilizes the BESTcare system to minimize medical errors during recovery.
| Republic of Korea | Turkey | Austria | |
| Transcatheter aortic valve implantation (TAVI) | from $28,500 | from $20,340 | from $40,000 |
| Replacement of the aortic valve | from $28,500 | from $20,340 | from $35,000 |
| Plastic surgery for cardiac valve | from $28,500 | from $8,000 | from $35,000 |
| Heart Valve Replacement | from $27,500 | from $15,470 | from $70,000 |
| Valvuloplasty | - | from $15,000 | from $40,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Aortic valve insufficiency treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Aortic valve insufficiency treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Aortic valve insufficiency treatment journey.
Dr. Paik Nam-sun is a world-renowned surgeon in the field of breast cancer, thyroid cancer, and surgical oncology. He is the first in South Korea to have successfully performed the breast conserving surgery and has authored a unique stomach cancer surgery that reduces the risk of gastroesophageal reflux disease. He is an expert in the diagnosis and management of breast cancer and a member of the Korean Society of Cancer Prevention and the Korean Cancer Association.